FDA Approves Apligraf for Treatment of Diabetic Foot Ulcers—Live Skin Used to Heal Foot Wounds

Aug 1, 2000

Only a month and 12 days after receiving recommendation for approval from a FDA advisory board, Apligraf was formally given approval for the treatment of diabetic foot ulcers of greater than a three-week duration.

Apligraf, supplied as a bi-layered living skin substitute, received FDA marketing clearance in 1998 for use in the treatment of venous leg ulcers. In clinical trials, Apligraf was shown to heal more diabetic foot ulcers faster than conventional therapy alone. By 12 weeks of treatment, 56 percent of diabetic foot ulcers treated with Apligraf were 100 percent closed, compared to 39 percent treated with conventional therapy alone.

"Apligraf will change the way we manage our patients with diabetic foot ulcers," says Lawrence B. Harkless, DPM, professor of podiatric medicine and surgery at the University of Texas Health Sciences Center in San Antonio, Texas. "The burden of diabetic foot ulcers to individuals and society demonstrates the need for new and better products to treat these devastating wounds."

Between 600,000 to 800,000 people in the United States currently suffer from diabetic foot ulcers.

For more information, call 781-575-0775.

Click Here To View Or Post Comments

Categories: Diabetes, Diabetes, Foot Care, Government & Policy, Wound Care

Take the Diabetes Health Pump Survey
See What's Inside
Read this FREE issue now
For healthcare professionals only
  • 12th Annual Product Reference Guide
  • Insulin Syringe Chart
  • Insulin Pen Needles Chart
  • Fast-Acting Glucose
  • Sharps Disposal
  • Blood Glucose Meters Chart
  • Insulin Pumps Chart
See the entire table of contents here!

You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View

See if you qualify for our free healthcare professional magazines. Click here to start your application for Pre-Diabetes Health, Diabetes Health Pharmacist and Diabetes Health Professional.

Learn More About the Professional Subscription

Free Diabetes Health e-Newsletter

Top Rated
Print | Email | Share | Comments (0)

You May Also Be Interested In...


Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Username: Password:
©1991-2015 Diabetes Health | Home | Privacy | Press | Advertising | Help | Contact Us | Donate | Sitemap

Diabetes Health Medical Disclaimer

The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.